Keywords: فیبریلاسیون دهلیزی غیر Valvular; PS; phosphatidylserine; NVAF; non-valvular atrial fibrillation; MPs; microparticles; PCA; procoagulant activity; RDW; red cell distribution width; PMPs; platelet-derived MPs; EMPs; endothelial-derived MPs; LMPs; leukocyte-derived MPs; WBC; white blood cel
مقالات ISI فیبریلاسیون دهلیزی غیر Valvular (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فیبریلاسیون دهلیزی غیر Valvular; AF; atrial fibrillation; AMI; acute myocardial infarction; ASMD; absolute standardized mean difference; GIB; gastrointestinal bleeding; ICD-9-CM; International Classification of Diseases-Ninth Revision-Clinical Modification; ICD-10-CM; International Class
Keywords: فیبریلاسیون دهلیزی غیر Valvular; AHA/ACC; American Heart Association/American College of Cardiology; APTT; active partial thromboplastin time; AR chip; chip for mixed white thrombus analysis; ATIII; antithrombin III; AUC; area under the flow pressure curve; DAP; diastolic arterial blood
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; Prognosis; Von Willebrand factor; Stroke; Cardiovascular events; Fibrillation atriale non valvulaire; Pronostic; Facteur von Willebrand; Infarctus cérébral; Ãvènements cardiovasculaires; AF; atrial fibrillation; CHADS
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Coronary artery disease; Medicare; Non-valvular atrial fibrillation; Oral anticoagulants; Peripheral artery disease; Stroke;
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; Stroke; Bleeding event; Healthcare database; Validation;
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Direct oral anticoagulants; Warfarin; Non-valvular atrial fibrillation; Renal function;
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Dabigatran etexilate; Novel oral anticoagulant; Cardiogenic cerebral embolism; Non-valvular atrial fibrillation; Real-world study
Keywords: فیبریلاسیون دهلیزی غیر Valvular; AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular Atrial Fibrillation; Warfarin; Time in therapeutic range;
Keywords: فیبریلاسیون دهلیزی غیر Valvular; NVAF; Non-valvular atrial fibrillation; TE; Thromboembolism; CHADS2; Congestive heart failure, Hypertension, Age â¥Â 75 years, Diabetes, previous Stroke; CHA2DS2-VASc; Congestive heart failure, Hypertension, Age â¥Â 75 years, Diabetes, previous Stro
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Anticoagulant; Vitamin k antagonist; Apixaban; Non-valvular atrial fibrillation; Stroke;
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: فیبریلاسیون دهلیزی غیر Valvular; AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر Valvular; DOAC; direct oral anticoagulant; NVAF; non-valvular atrial fibrillation; ATC; Anatomic Therapeutic Classification system; ICD-10; International Classification of Diseases version 10; HR; hazard ratio; CI; confidence interval; TIA; transient ischemic attac
Perfil clÃnico de pacientes con fibrilación auricular tratados con anticoagulantes orales de acción directa atendidos en atención primaria. Estudio SILVER-AP
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Anticoagulación; Anticoagulantes orales de acción directa; Atención primaria; Fibrilación auricular no valvular; Anticoagulation; Direct oral anticoagulants; Primary care; Non-valvular atrial fibrillation;
Adecuación del tratamiento antitrombótico en los pacientes con fibrilación auricular no valvular. Registro AFINVA
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Tratamiento antitrombótico; Anticoagulación oral; Fibrilación auricular no valvular; Registro AFINVA; Antithrombotic treatment; Oral anticoagulation; Non-valvular atrial fibrillation; AFINVA register;
Diferencias en el manejo de los pacientes con fibrilación auricular según inicie el tratamiento con anticoagulantes orales de acción directa el médico de atención primaria o el especialista. Estudios SILVER-AP y BRONCE-AP
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Anticoagulación; Anticoagulantes orales de acción directa; Atención primaria; Fibrilación auricular no valvular; Anticoagulation; Direct oral anticoagulants; Primary care; Non-valvular atrial fibrillation;
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
Keywords: فیبریلاسیون دهلیزی غیر Valvular; ACC; American College of Cardiology; ACS; Acute Coronary Syndrome; ACT; Activated Clotting Time; AF; Atrial Fibrillation; AHA; American Heart Association; aPCC; Activated Prothrombin Complex Concentrate; aPTT; Activated Partial Thromboplastin Time; CAD; C
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر Valvular; AF; atrial fibrillation; CrCl; creatinine clearance; ISTH; International Society on Thrombosis and Haemostasis; NOAC; non-vitamin K antagonist OACs; NVAF; non-valvular atrial fibrillation; OAC; oral anticoagulant; PT-INR; prothrombin time-international no
Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; NOACs; Stroke prevention; Middle East and North Africa;
Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivarox
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Anticoagulants; DOAC; Non-valvular atrial fibrillation; Stroke; General practitioner;
Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; Elderly; Antithrombotic treatment; Fibrilación auricular no valvular; Ancianos; Tratamiento antitrombótico;
CaracterÃsticas y tratamiento antitrombótico de los pacientes ancianos con fibrilación auricular no valvular hospitalizados en Medicina Interna. Registro NONAVASC
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Fibrilación auricular no valvular; Ancianos; Tratamiento antitrombótico; Non-valvular atrial fibrillation; Elderly; Antithrombotic treatment;
Control de la anticoagulación en pacientes con fibrilación auricular no valvular en práctica clÃnica de atención primaria en las diferentes comunidades autónomas. Estudio PAULA
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Fibrilación auricular no valvular; Antagonistas vitamina K; Control INR; Rosendaal; Non-valvular atrial fibrillation; Vitamin K antagonists; INR monitoring; Rosendaal;
Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry
Keywords: فیبریلاسیون دهلیزی غیر Valvular; LAA closure; Stroke; Prevention; Device; ACP; Amplatzer Cardiac Plug; ASA; acetylsalicylic acid; ACT; activated clotting time; AF; atrial fibrillation; ICB; intracranial bleeding; LAA; left atrial appendage; LAAO; left atrial appendage occlusion; NVAF; no
Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; Vitamin-K antagonists; Non-vitamin K antagonist oral anticoagulants
The HIPOGAIA study: Monitoring of oral anticoagulation with vitamin K antagonists in the municipality of Gaia
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Primary health care; Oral vitamin K antagonists; Non-valvular atrial fibrillation; Time in therapeutic rangeCuidados de saúde primários; Hipocoagulantes orais dicumarínicos; Fibrilhação auricular não valvular; Tempo em intervalo terapêutico
Análisis de la tendencia temporal en el mal control de los pacientes anticoagulados en una cohorte de pacientes de atención primaria
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Tiempo en rango terapéutico; Anticoagulación; Fibrilación auricular no valvularTime in therapeutic range; Anticoagulation; Non-valvular atrial fibrillation
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; Chronic kidney disease; Stroke; Major bleeding; Clinical outcomes
Análisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en España
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Apixabán; Ácido acetilsalicílico; Coste-utilidad; Fibrilación auricular no valvularApixaban; Acetylsalicylic acid; Cost-effectiveness; Non-valvular atrial fibrillation
Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Non-valvular atrial fibrillation; Transesophageal echocardiography; Intracardiac thrombus; Dabigatran; Warfarin;
Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Dabigatran; Anticoagulants; aPTT; Non-valvular atrial fibrillation
Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level:: The Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study
Keywords: فیبریلاسیون دهلیزی غیر Valvular; AF; non-valvular atrial fibrillation; CHADS2; Congestive heart failure, Hypertension, Age â¥Â 75, Diabetes, Stroke [doubled]; CHA2DS2-VASc; Congestive heart failure/left ventricular dysfunction, Hypertension, Age 75 [doubled], Diabetes, Stroke [doubled]
¿Qué aportan los nuevos anticoagulantes en la prevención del tromboembolismo venoso y arterial?
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Nuevos anticoagulantes orales; Dabigatran; Rivaroxabán; Apixabán; Edoxabán; Profilaxis enfermedad tromboembólica en cirugÃa ortopédica; Tratamiento y prevención recurrencias en la enfermedad tromboembólica venosa; Fibrilación auricular no valvula
Beneficios de la anticoagulación oral en pacientes con ictus cardioembólico por fibrilación auricular no valvular
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Ictus isquémico; Fibrilación auricular no valvular; Anticoagulación; Warfarina; Ischaemic stroke; Non-valvular atrial fibrillation; Oral anticoagulation; Warfarin;
Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Anticoagulation therapy; Non-valvular atrial fibrillation
Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
Keywords: فیبریلاسیون دهلیزی غیر Valvular; NVAF; Non-valvular atrial fibrillation; VKA; Vitamin K antagonist; INR; International normalized ratio; DTI; Direct thrombin inhibitor; TTA; Total thrombus area; IR; Immediate-release; PK; Pharmacokinetic(s); PD; Pharmacodynamic(s); APTT; Activated partia
Atherothrombotic ischemic stroke in patients with atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر Valvular; Ischemic stroke; Non-valvular atrial fibrillation; Extracranial carotid artery disease; Definite cardioembolic stroke; Probable cardioembolic stroke; Possible lacunar infarction; Possible atherothrombotic stroke